Your browser doesn't support javascript.
loading
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients.
Golan, Talia; Grenader, Tal; Ohana, Patricia; Amitay, Yasmine; Shmeeda, Hilary; La-Beck, Ninh M; Tahover, Esther; Berger, Raanan; Gabizon, Alberto A.
Afiliación
  • Golan T; Sheba Medical Center, Tel HaShomer, Israel.
  • Grenader T; Shaare Zedek Medical Center, Jerusalem, Israel.
  • Ohana P; Lipomedix Pharmaceuticals Ltd., Jerusalem, Israel.
  • Amitay Y; Lipomedix Pharmaceuticals Ltd., Jerusalem, Israel.
  • Shmeeda H; Shaare Zedek Medical Center, Jerusalem, Israel.
  • La-Beck NM; Texas Tech University Health Sciences Center-School of Pharmacy, Abilene, Texas.
  • Tahover E; Shaare Zedek Medical Center, Jerusalem, Israel.
  • Berger R; Sheba Medical Center, Tel HaShomer, Israel.
  • Gabizon AA; Shaare Zedek Medical Center, Jerusalem, Israel.
Cancer Med ; 4(10): 1472-83, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26172205
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Profármacos / Mitomicina / Antibióticos Antineoplásicos / Neoplasias Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2015 Tipo del documento: Article País de afiliación: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Profármacos / Mitomicina / Antibióticos Antineoplásicos / Neoplasias Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2015 Tipo del documento: Article País de afiliación: Israel